Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vyvanse for Occupational Success in Young Adults with ADHD
NCT03446885Phase 4Completed
- Start
- Apr 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lisdexamfetamine in attention deficit hyperactivity disorder (ADHD). Started Apr 2018; status: completed.
02
Drugs
lisdexamfetamine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT03446885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03446885.